Literature DB >> 10580152

Genomic organization and promoter activity of embigin, a member of the immunoglobulin superfamily.

H Tachikui1, N Kurosawa, K Kadomatsu, T Muramatsu.   

Abstract

Embigin is a transmembrane glycoprotein belonging to the immunoglobulin superfamily, which is preferentially expressed in early stages of mouse embryogenesis and enhances integrin-mediated cell-substratum adhesion. The mouse embigin gene, which we cloned, spanned more than 50kb, in which nine exons were present. All exons contained protein-coding sequences. Each of the two immunoglobulin domains was encoded by two exons, and the C-proximal half of the second immunoglobulin domain and the transmembrane domain were in the same exon. These features are shared by the basigin gene; together with protein sequence homology, our results defined a family in the immunoglobulin superfamily, to which embigin and basigin both belong. The major transcriptional initiation site of embigin gene was 103 bases upstream from the translation initiation site, as determined by 5' rapid amplification of cDNA ends. A 3kb DNA fragment upstream from the transcriptional initiation site contained three Sp1 binding sites and had a promoter sequence capable of expressing the downstream gene not only in F9 embryonal carcinoma cells which express the gene, but also in L and G401 cells which do not, indicating the presence of a regulatory region outside the 3kb DNA region. Deletion analysis of the 3.5kb DNA fragment revealed that the region between -125 to +1, containing a single Sp1 binding site, is essential for transcription of the embigin gene.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10580152     DOI: 10.1016/s0378-1119(99)00445-x

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  7 in total

1.  Protein-bound carbohydrates on cell-surface as targets of recognition: an odyssey in understanding them.

Authors:  T Muramatsu
Journal:  Glycoconj J       Date:  2000 Jul-Sep       Impact factor: 2.916

Review 2.  Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.

Authors:  Stephen J Fairweather; Nishank Shah; Stefan Brӧer
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  Basigin (CD147), a multifunctional transmembrane glycoprotein with various binding partners.

Authors:  Takashi Muramatsu
Journal:  J Biochem       Date:  2015-12-18       Impact factor: 3.387

4.  Embigin, regulated by HOXC8, plays a suppressive role in breast tumorigenesis.

Authors:  Fengmei Chao; Jun Zhang; Yang Zhang; Houli Liu; Chenchen Yang; Juan Wang; Yanjun Guo; Xiaohong Wen; Kaiye Zhang; Bei Huang; Daihai Liu; Yong Li
Journal:  Oncotarget       Date:  2015-09-15

5.  Genomic deletion of GIT2 induces a premature age-related thymic dysfunction and systemic immune system disruption.

Authors:  Sana Siddiqui; Ana Lustig; Arnell Carter; Mathavi Sankar; Caitlin M Daimon; Richard T Premont; Harmonie Etienne; Jaana van Gastel; Abdelkrim Azmi; Jonathan Janssens; Kevin G Becker; Yongqing Zhang; William Wood; Elin Lehrmann; James G Martin; Bronwen Martin; Dennis D Taub; Stuart Maudsley
Journal:  Aging (Albany NY)       Date:  2017-03-04       Impact factor: 5.682

6.  Embigin Promotes Prostate Cancer Progression by S100A4-Dependent and-Independent Mechanisms.

Authors:  I Made Winarsa Ruma; Rie Kinoshita; Nahoko Tomonobu; Yusuke Inoue; Eisaku Kondo; Akira Yamauchi; Hiroki Sato; I Wayan Sumardika; Youyi Chen; Ken-Ichi Yamamoto; Hitoshi Murata; Shinichi Toyooka; Masahiro Nishibori; Masakiyo Sakaguchi
Journal:  Cancers (Basel)       Date:  2018-07-23       Impact factor: 6.639

7.  Rewiring of Cancer Cell Metabolism by Mitochondrial VDAC1 Depletion Results in Time-Dependent Tumor Reprogramming: Glioblastoma as a Proof of Concept.

Authors:  Tasleem Arif; Oriel Stern; Srinivas Pittala; Vered Chalifa-Caspi; Varda Shoshan-Barmatz
Journal:  Cells       Date:  2019-10-28       Impact factor: 7.666

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.